ARTEMIS: Efficacy and safety of lopinavir (BID vs QD) and darunavir (QD) in antiretroviral-naïve patients by Assoc. Prof. Jan Van Lunzen given during the 11th European AIDS Conference / EACS powered by - MULTIWEBCAST

11th European AIDS Conference / EACS

LIST OF PRESENTATIONS

OTHER WEBCASTS

Webcasted Presentation

BROWSE:

Assoc. Prof. Jan Van Lunzen

Germany

Biography

ARTEMIS: Efficacy and safety of lopinavir (BID vs QD) and darunavir (QD) in antiretroviral-naïve patients

English

2007-10-26

PRESENTATION

16 slide(s)

Extra Features Available

SLIDE LIBRARY

Disclaimer ^{AMENDED ON January 29, 2009} | Close This Window | Technical Support

USER ACKNOWLEDGES AND AGREES THAT ALL DECISIONS MADE WITH THE ASSISTANCE OR USE OF THE SOFTWARE AND/OR THE WEBSITE AND/OR BASED ON CONTENT FOUND HEREIN WILL BE EXCLUSIVELY THE RESPONSIBILITY OF THE USER.

Search’n Build™ Search presentations by keyword and instantly build your own highlight of the conference!

Search’n Build™
Search presentations by keyword and instantly build your own highlight of the conference!